Intelligence / Healthtech / New Clinical Trials / Hoffmann-La Roche
Clinicaltrial registered20 Oct 2026
Hoffmann-La Roche
20 Oct 2026: Trial registered · A Study of RO7821657 in Participants With Solid Tumors. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 20 Oct 2026
- Title
- A Study of RO7821657 in Participants With Solid Tumors
- Conditions
- Locally Advanced or Metastatic Solid Tumors
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Denmark, United Kingdom
- Country
- Denmark
- Reference
- NCT07883577
- Location
- Denmark, United Kingdom
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Hoffmann-La Roche
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Hoffmann-La Roche in our registers.
16 NovHoffmann-La Rochetrial registered · HealthtechClinical5 NovHoffmann-La Rochetrial registered · HealthtechClinical30 OctHoffmann-La Rochetrial registered · HealthtechClinical22 OctHoffmann-La Rochetrial registered · HealthtechClinical
More from Denmark
New Clinical Trials
18 NovAmbu A/Strial registered · AI-Guided Bronchoscopy Using the Broncho AI NavigatorClinical12 NovNovo Nordisk A/Strial registered · AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothClinical10 NovMipSalus Apstrial registered · A First-in-Human Study of Phelimin in Healthy Volunteers and Adults With PKUClinical5 NovNovo Nordisk A/Strial registered · A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical2 NovHerAccess ApStrial registered · Integrated Care Pathway for Hormonally Mediated Vestibulodynia: a Feasibility and Acceptability PilotClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.